HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ?

HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ?

Background: Direct-acting antiviral (DAA)-based treatment of hepatitis C virus (HCV) has been associated with high sustained virological response (SVR) rates and good tolerability in randomized clinical trials. This study was performed to assess the safety and effectiveness of DAAs in both HCV mono-...

Full description

Bibliographic Details
Main Authors: Giuseppe Bruno, Annalisa Saracino, Luigia Scudeller, Claudia Fabrizio, Raffaele Dell’Acqua, Eugenio Milano, Michele Milella, Nicoletta Ladisa, Laura Monno, Gioacchino Angarano
Format: Article
Language:English
Published: Elsevier 2017-09-01
Series:International Journal of Infectious Diseases
Subjects:
Direct-acting antivirals
DAAs
SVR
Safety
HIV/HCV co-infection
Real world
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971217301790

Internet

http://www.sciencedirect.com/science/article/pii/S1201971217301790

Similar Items